Transspinal Stimulation + Locomotor Training for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a method to help people with spinal cord injuries improve their ability to walk. It combines a special type of physical therapy called locomotor training with electrical spinal stimulation, which might boost recovery. Participants will receive either real or sham (inactive) stimulation before their therapy sessions. This study suits those with a motor-incomplete spinal cord injury, meaning they still have some movement or sensation below the injury. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could enhance rehabilitation methods for spinal cord injuries.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes people taking medications that may change the seizure threshold. It's best to discuss your specific medications with the trial team.
What prior data suggests that transspinal stimulation and locomotor training are safe for spinal cord injury patients?
Research shows that transspinal stimulation is generally safe. Studies on similar treatments, such as transcutaneous spinal cord stimulation, indicate they are well-tolerated, with few side effects reported by users.
One study found that combining spinal stimulation with activity-based training improved movement in people with spinal cord injuries after several sessions. This suggests the treatment is not only effective but also safe over time. Another study reviewed spinal cord stimulation and found it to be safe, with few adverse effects.
While these findings are encouraging, it's important to remember that this specific trial's treatment is still under investigation. However, existing research suggests the treatment is likely safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because transspinal stimulation combined with locomotor training could offer new hope for people with spinal cord injuries. Unlike traditional therapies like physical therapy and conventional gait training, these methods involve delivering electrical stimulation to the spinal cord, either during standing or while lying down, to potentially enhance neural connections and promote movement. The addition of robotic gait training provides controlled, supportive movement, which might lead to improved recovery outcomes. This approach is particularly promising because it may help activate and strengthen neural pathways in a way that conventional methods do not, potentially leading to better mobility and independence for patients.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that transspinal stimulation could help people with spinal cord injuries regain movement. This trial will evaluate different approaches to transspinal stimulation. One group will receive real transspinal stimulation while standing, and another will receive it while lying supine. Both groups will follow this with locomotor training. A sham group will receive transspinal stimulation at an intensity where sensation is absent during standing, followed by locomotor training. This technique can activate important muscles, potentially improving movement and walking ability. When combined with other treatments, transspinal stimulation has helped people recover more function after a spinal cord injury. It is noninvasive, meaning it doesn't involve surgery, and studies have found it to be safe. Early results are promising, suggesting it could improve walking ability when used with walking training.24567
Who Is on the Research Team?
Noam Y Harel, MD PhD
Principal Investigator
Bronx Veterans Medical Research Foundation
Maria Knikou, PT, PhD
Principal Investigator
Research Foundation of the City University of New York
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 with motor-incomplete spinal cord injury (SCI) above the T10 level, who can sign consent and commit to the study duration. They must be in good health, have a bone mineral density T-score <3.5 SD from norms, reflexes present for soleus H-reflex testing, flexible ankle joints without contractures, first-time SCI due to trauma or similar causes, and at least 6 months post-SCI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 40 sessions of body weight-supported step training primed with high-frequency transspinal stimulation
Follow-up
Participants are monitored for changes in spinal and corticospinal plasticity, ambulatory function, balance, and autonomic function
What Are the Treatments Tested in This Trial?
Interventions
- Robotic Gait Training
- Transspinal Stimulation
Robotic Gait Training is already approved in European Union, United States, Canada, Switzerland for the following indications:
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
City University of New York
Lead Sponsor
Bronx Veterans Medical Research Foundation, Inc
Collaborator
Icahn School of Medicine at Mount Sinai
Collaborator